Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bergshoeff

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Journal of Thrombosis and Haemostasis : JTH|April 22, 2004
Migration of the activation peptide of thrombin-activatable fibrinolysis inhibitor (TAFI) during SDS-polyacrylamide gel electrophoresisA H C Guimarães, M M Barrett-Bergshoeff, A Gils, et al.
Thrombosis and Haemostasis|December 24, 2003
Clot penetration and fibrin binding of amediplase,a chimeric plasminogen activator (K2 tu-PA)Dingeman C Rijken, Marrie M Barrett-Bergshoeff, A F H Jie, et al.
Journal of Chemical Ecology|November 16, 2013
The "Raison D'être" of pyrrolizidine alkaloids inCynoglossum officinale: Deterrent effects against generalist herbivoresN M van Dam, L W Vuister, C Bergshoeff, et al.
Hepatology (Baltimore, Md.)|July 1, 1992
Isolation and characterization of the mannose receptor from human liver potentially involved in the plasma clearance of tissue-type plasminogen activatorM Otter, P Zocková, J Kuiper, et al.
Journal of Leukocyte Biology|January 1, 1997
Monoclonal antibodies against the human mannose receptor as a specific marker in flow cytometry and immunohistochemistry for macrophagesF Noorman, E A Braat, M Barrett-Bergshoeff, et al.
The Pediatric Infectious Disease Journal|October 13, 2005
Pharmacokinetics and 24-week efficacy/safety of dual boosted saquinavir/lopinavir/ritonavir in nucleoside-pretreated childrenJintanat Ananworanich, Pope Kosalaraksa, Andrew Hill, et al.
Thrombosis and Haemostasis|August 3, 2002
Characterization of the binding of urokinase-type plasminogen activator to the asialoglycoprotein receptorD C Rijken, M E van der Kaaden, E Groeneveld, et al.
The Journal of Pediatrics|September 3, 2004
Maintaining the nelfinavir trough concentration above 0.8 mg/L improves virologic response in HIV-1-infected childrenDavid M Burger, Alina S Bergshoeff, Ronald De Groot, et al.
Hepatology (Baltimore, Md.)|November 15, 1997
Cluster mannosides can inhibit mannose receptor-mediated tissue-type plasminogen activator degradation by both rat and human cellsF Noorman, M M Barrett-Bergshoeff, E A Biessen, et al.
The Journal of Antimicrobial Chemotherapy|August 15, 2003
Changes in indinavir exposure over time: a case study in six HIV-1-infected childrenP L A Fraaij, A S Bergshoeff, A M C van Rossum, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Journal of Thrombosis and Haemostasis : JTH|April 22, 2004
Migration of the activation peptide of thrombin-activatable fibrinolysis inhibitor (TAFI) during SDS-polyacrylamide gel electrophoresisA H C Guimarães, M M Barrett-Bergshoeff, A Gils, et al.
Thrombosis and Haemostasis|December 24, 2003
Clot penetration and fibrin binding of amediplase,a chimeric plasminogen activator (K2 tu-PA)Dingeman C Rijken, Marrie M Barrett-Bergshoeff, A F H Jie, et al.
Journal of Chemical Ecology|November 16, 2013
The "Raison D'être" of pyrrolizidine alkaloids inCynoglossum officinale: Deterrent effects against generalist herbivoresN M van Dam, L W Vuister, C Bergshoeff, et al.
Hepatology (Baltimore, Md.)|July 1, 1992
Isolation and characterization of the mannose receptor from human liver potentially involved in the plasma clearance of tissue-type plasminogen activatorM Otter, P Zocková, J Kuiper, et al.
Journal of Leukocyte Biology|January 1, 1997
Monoclonal antibodies against the human mannose receptor as a specific marker in flow cytometry and immunohistochemistry for macrophagesF Noorman, E A Braat, M Barrett-Bergshoeff, et al.
The Pediatric Infectious Disease Journal|October 13, 2005
Pharmacokinetics and 24-week efficacy/safety of dual boosted saquinavir/lopinavir/ritonavir in nucleoside-pretreated childrenJintanat Ananworanich, Pope Kosalaraksa, Andrew Hill, et al.
Thrombosis and Haemostasis|August 3, 2002
Characterization of the binding of urokinase-type plasminogen activator to the asialoglycoprotein receptorD C Rijken, M E van der Kaaden, E Groeneveld, et al.
The Journal of Pediatrics|September 3, 2004
Maintaining the nelfinavir trough concentration above 0.8 mg/L improves virologic response in HIV-1-infected childrenDavid M Burger, Alina S Bergshoeff, Ronald De Groot, et al.
Hepatology (Baltimore, Md.)|November 15, 1997
Cluster mannosides can inhibit mannose receptor-mediated tissue-type plasminogen activator degradation by both rat and human cellsF Noorman, M M Barrett-Bergshoeff, E A Biessen, et al.
The Journal of Antimicrobial Chemotherapy|August 15, 2003
Changes in indinavir exposure over time: a case study in six HIV-1-infected childrenP L A Fraaij, A S Bergshoeff, A M C van Rossum, et al.
Pageof 6